✦ LIBER ✦

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix® 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study

✍ Scribed by S. Shah; M. Benroubi; V. Borzi; J. Gumprecht; R. Kawamori; J. Shaban; M. Shestakova; Y. Wenying; P. Valensi; on behalf of the IMPROVE™ Study Group Expert Panel

Book ID: 111308957
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 125 KB
Volume: 63
Category: Article
ISSN: 1368-5031
DOI: 10.1111/j.1742-1241.2009.02012.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Initiating insulin therapy with, or swit

Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix® 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study

✍ P. Valensi; M. Benroubi; V. Borzi; J. Gumprecht; R. Kawamori; J. Shaban; S. Shah 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

PDB4 LONG-TERM OUTCOMES OF SWITCHING PAT

PDB4 LONG-TERM OUTCOMES OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM BIPHASIC INSULIN TO BIPHASIC INSULIN ASPART 30/70: AN IMPROVE STUDY SUBGROUP ANALYSIS

✍ R Ligthelm; TE Christensen; TL Thomsen; W Yang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Intensification to biphasic insulin aspa

Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™ observational study

✍ J. Gumprecht; M. Benroubi; V. Borzi; R. Kawamori; J. Shaban; S. Shah; M. Shestak 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

PDB24 COST EFFECTIVENESS ANALYSIS OF SWI

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

✍ E Suchankova; T Doležal; Z Pisarikova; K Rychna; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Biphasic insulin aspart 30 in the treatm

Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMix®study

✍ H. C. Jang; S. R. Lee; J. A. Vaz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

P-28 Switching patients from human premi

P-28 Switching patients from human premix insulin to biphasic insulin aspart 30 leads to improved glycaemic control: a subgroup analysis of Korean patients with Type 2 diabetes in the PRESENT study

✍ Seung Joon Oh; Jong Hwa Kim; SukO. Park; Suk ManSon; Sun Kyung Song; So Ra Lee 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB